Financhill
Back

Prothena Corp PLC 10K Form

Sell
16

PRTA
Prothena Corp PLC

Last Price:
$15.41
Seasonality Move:
10.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive PRTA News And Ratings

See the #1 stock for the next 7 days that we like better than PRTA

PRTA Financial Statistics

Sales & Book Value

Annual Sales: $91.4M
Cash Flow: $-45.2M
Price / Cash Flow: 0
Annual Sales: $9.93
Price / Book: 1.54

Profitability

EPS (TTM): -2.48000
Net Income (TTM): $-131.8M
Gross Margin: $0
Return on Equity: -23.56%
Return on Assets: -19.93%

Prothena Corp PLC Earnings Forecast

Key Prothena Corp PLC Financial Ratios

  • The Gross Profit Margin over the past 5 years for PRTA is 0.00%.
  • The Selling, General & Administrative Expenses for PRTA have been equal to 67.68% of Gross Profit Margin.
  • The Research & Development expenses have been 241.40% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of PRTA is -160.91% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 6 years.

Prothena Corp PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PRTA
CUSIP: G72800
Website: prothena.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 11.52
Quick Ratio: 11.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRTA Technical Analysis vs Fundamental Analysis

Sell
16
Prothena Corp PLC (PRTA) is a Sell

Is Prothena Corp PLC a Buy or a Sell?

  • Prothena Corp PLC stock is rated a Sell
    The current Prothena Corp PLC [PRTA] share price is $15.33. The Score for PRTA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.